文献速递耳科与耳神经

高压氧与突发性感音神经性听力损失:系统综述与Meta分析

Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis.
PubMed 文献 · Laryngoscope · 2025-08-01

该系统综述与Meta分析检索多个数据库至2025年5月7日,纳入20项研究(16项随机对照试验和4项非随机前瞻性研究),共涉及接受高压氧治疗的1087例患者和仅接受药物治疗的600例患者。其中10项研究进入Meta分析,结果显示高压氧联合药物治疗组听力恢复的比值比为2.61(95%CI 1.86-3.68,p<0.001),高于单纯药物治疗组。结论认为高压氧联合药物治疗可能对突发性感音神经性听力损失患者的听力恢复有益,但需标准化治疗方案和数据报告以得出更确切结论。

要点

  • 高压氧联合药物治疗组听力恢复的比值比为2.61(95%CI 1.86-3.68,p<0.001),高于单纯药物治疗组。
  • 高压氧联合全身类固醇组听力恢复的比值比为2.54(95%CI 1.63-3.97,p<0.001),高于单纯全身类固醇组。
  • 高压氧联合全身类固醇及鼓室内类固醇组听力恢复的比值比为2.64(95%CI 1.39-5.02,p<0.001),高于单纯全身类固醇及鼓室内类固醇组。

核心结论

  • 高压氧联合药物治疗可能对突发性感音神经性听力损失患者的听力恢复有益,但需标准化治疗方案和数据报告以得出更确切结论。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、CENTRAL、MEDLINE、Google Scholar、Web of Science和Clinicaltrials.gov至2025年5月7日。
  • 纳入20项研究(16项随机对照试验和4项非随机前瞻性研究),共涉及接受高压氧治疗的1087例患者和仅接受药物治疗的600例患者。
  • 其中10项研究纳入Meta分析,采用随机效应模型计算合并比值比。

主要发现

  • 高压氧联合药物治疗组听力恢复的比值比为2.61(95%CI 1.86-3.68,p<0.001),高于单纯药物治疗组。
  • 高压氧联合全身类固醇组听力恢复的比值比为2.54(95%CI 1.63-3.97,p<0.001),高于单纯全身类固醇组。
  • 高压氧联合全身类固醇及鼓室内类固醇组听力恢复的比值比为2.64(95%CI 1.39-5.02,p<0.001),高于单纯全身类固醇及鼓室内类固醇组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sudden sensorineural hearing loss (SSNHL) Remains a significant enigma, despite its profound impacts on affected individuals. Hyperbaric oxygen therapy (HBOT) has gained significant attention as a potential treatment, but its use remains controversial. We aimed to perform a systematic review and meta-analysis assessing the efficacy of HBOT in treating SSNHL. DATA SOURCES: PubMed, EMBASE, CENTRAL, MEDLINE, Google Scholar, Web of Science, and Clinicaltrials.gov were searched through May 7, 2025. REVIEW METHODS: Two investigators independently screened articles and extracted data in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A meta-analysis calculated pooled odds ratios (ORs) using a random-effects model. RESULTS: Twenty studies (16 RCTs and four non-randomized prospective studies) were included; in total, these studies investigated 1087 patients receiving HBOT and 600 receiving medical therapy (MT) alone. Ten studies were included in a meta-analysis, which found that patients receiving HBOT in combination with MT had 2.61 higher odds of experiencing hearing recovery than those treated with MT alone (95% CI 1.86-3.68, p < 0.001). Subgroup analyses for HBOT + systemic steroids (SS) vs. SS alone and HBOT + SS + intratympanic steroids (ITS) vs. SS + ITS alone found higher odds of hearing recovery with HBOT (OR 2.54, 95% CI 1.63-3.97, p < 0.001 and OR 2.64, 95% CI 1.39-5.02, p < 0.001, respectively). CONCLUSION: The combination of HBOT with MT is likely to provide benefit in hearing recovery for individuals with SSNHL. However, ongoing work should seek to standardize treatment protocols and data reporting to allow for more definitive conclusions.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Alter IL, Hamiter M, Han J, et al. Hyperbaric Oxygen and Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis. Laryngoscope. 2025. PMID: 40747804. doi:10.1002/lary.32472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。